JN.1 variant
Healthcare
FDA Approves Novavax COVID Vaccine After Pfizer and Moderna
On Friday, the Food and Drug Administration (FDA) granted approval for an updated COVID-19 vaccine developed by Novavax, following the previous week’s endorsement...
Healthcare
FDA Panel Backs New COVID Vaccines for JN.1 Variant by Fall
An expert panel from the Food and Drug Administration (FDA) voted unanimously on Wednesday to develop new COVID-19 vaccines specifically targeting the JN.1...
